Management strategies for metabolic dysfunction–associated steatotic liver disease (MASLD)
The American Journal of Managed Care · 01.11.2024 · 30 (Suppl 9) · S159-S174
DOI: 10.37765/ajmc.2024.89635 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The American Journal of Managed Care, online erschienen am 07.11.2024. Verfasst von Naim Alkhouri und 1 weiteren Autor:innen. Beteiligte Einrichtung: Arizona Liver Health, Tucson Liver Clinic, 1601 North Swan Road, Tucson, AZ 85712. Email: naim.alkhouri@gmail.com. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 20-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Arizona Liver Health, Tucson Liver Clinic, 1601 North Swan Road, Tucson, AZ 85712. Email: naim.alkhouri@gmail.com.
Zitieren
APA
Alkhouri, N., & Noureddin, M. (2024). Management strategies for metabolic dysfunction–associated steatotic liver disease (MASLD). The American Journal of Managed Care, 30(Suppl 9), S159-S174. https://doi.org/10.37765/ajmc.2024.89635
Vancouver
Alkhouri N, Noureddin M. Management strategies for metabolic dysfunction–associated steatotic liver disease (MASLD). The American Journal of Managed Care. 2024;30(Suppl 9):S159-S174. doi:10.37765/ajmc.2024.89635
BibTeX
@article{Alkhouri2024,
author = {Alkhouri, Naim and Noureddin, Mazen},
title = {Management strategies for metabolic dysfunction–associated steatotic liver disease (MASLD)},
journal = {The American Journal of Managed Care},
year = {2024},
volume = {30},
number = {Suppl 9},
pages = {S159--S174},
doi = {10.37765/ajmc.2024.89635}
}
EUVIMED